• Catalan
  • Dutch
  • English
  • Spanish
Health Outcomes Observatory
  • Home
  • Project
    • About H2O
    • Vision & Objectives
    • Impact
    • Work Packages
    • Governance
  • Participants
    • Partners
    • Associated Collaborators
    • Advisory Boards
  • Observatories
    • What are the Observatories?
    • How do they work?
  • Patients
    • H2O, with and for patients
    • FAQs
    • PROs Leaflet
  • News
    • News
    • Press Releases & Announcements
    • Events
    • Blogs
  • Resources
    • Publications
    • Deliverables
    • Factsheets
  • Contact
  • Search
  • Menu Menu
  • Home
  • Project
    • About H2O
    • Vision & Objectives
    • Impact
    • Work Packages
    • Governance
  • Participants
    • Partners
    • Associated Collaborators
    • Advisory Boards
  • Observatories
    • What are the Observatories?
    • How do they work?
  • Patients
    • H2O, with and for patients
    • FAQs
    • PROs Leaflet
  • News
    • News
    • Press Releases & Announcements
    • Events
    • Blogs
  • Resources
    • Publications
    • Deliverables
    • Factsheets
  • Contact

Study shows integration with health care systems remains critical to success

17th December 2021/in blog, news /by h2o

By Linetta Koppert, member of the H2O Initiative and Oncological surgeon, clinical epidemiologist, MD PhD at Erasmus MC responds to new data from ASCO

We at H2O welcome the presentation of secondary endpoints from the PRO-TECT study related to patient reported outcomes (PROs) and intervention feasibility. These finding, presented as part of the #ASCOPlenarySeries, demonstrate simple electronic systems can be effective in tracking PROs, resulting in significant improvements in symptom management and better clinical outcomes. The authors state that at 3 months, patients who tracked PROs reported benefits in physical function, symptom control and quality-of-life above that of the control group.

The PRO-TECT study is a randomized trial conducted at 52 U.S. community oncology practices across 25 states. The study abstract and a comprehensive summary of the presentation given by Ethan Basch, MD, MSc, of the UNC Lineberger Comprehensive Cancer Center and principal investigator of the PRO-TECT study, during the November ASCO Plenary Series is available here.

It is so important to see published data on the improvements in outcomes; this is the driving force behind everything we do on the H2O Initiative. It is also further evidence of the challenges we face in gathering PROs in a way which doesn’t increase the burden on health systems.

We believe it really is possible to reduce the burden on the healthcare system while improving outcomes. In my own clinical practice for breast cancer, my colleagues and I are already encouraging patients to feel confident in reporting quality of life outcomes. We help them understand this important data for us to know. The small amount of time it takes to proactively share is far outweighed by the benefit of being able to review treatment options, and where necessary, make adjustments. It does require a little effort on both sides, but we see that it leads to patients getting the best possible support.

In my own clinical practice for breast cancer, my colleagues and I are already encouraging patients to feel confident in reporting quality of life outcomes. We help them understand this important data for us to know.

What really stands out for us in the PRO-TECT study, aside from the excellent results for the patients, is the authors’ consideration of user experience, for both patients and clinicians. The study appears to have been designed to be as easy as possible for patients to use, even those with little experience with technology. They report an average patient compliance rate of 91%, which is truly impressive. However, the authors sound a note of caution: ‘Although 90% of patients said they would recommend the intervention to other patients based on their experience, only 64% of nurses would recommend the PRO system to other clinics. The burden of managing alert notifications on top of usual duties was a key reason cited by the nurses who would not recommend the PRO system.’

This very much aligns with our understanding of some of the challenges with gathering PROs, and demonstrates that we must continue to find solutions which integrate with existing healthcare systems. We recognise this is very difficult to do on large scale. We must think differently. And this is the H2O unique proposition; to discover the most practical ways to introduce continuous outcome measurement in clinical practice. We are finding new ways to leverage technologies and unleashing innovation to create efficiencies, reducing the burden for the healthcare system.

This is the H2O unique proposition; to discover the most practical ways to introduce continuous outcome measurement in clinical practice.

The PRO-TECT study authors make some recommendations around reducing this burden, including allocating specific time to front desk staff and nurses. It’s this sort of practical approach which is needed, alongside appropriate technologies. Our ambition with H2O is to create a standardized language for multiple diseases across multiple countries. We believe a one-size fits all approach would not work, so alongside finding excellent technology solutions, a significant focus of our partnerships with technology providers will concentrate on how we can integrate with existing healthcare systems in a way which is as seamless as possible.

We do believe the future is bright since ‘patient journey app-initiatives’ are being broadly introduced in healthcare, supporting implementation of PROs. We encourage this real transformation of healthcare not only by creating a standardized outcomes language but moreover by  implementing technology.

Studies like PRO-TECT continue to give us evidence that using PROs can be transformational, and provide encouragement that we are right to focus on bringing healthcare providers, as well as patients, along on the journey with us.

Tags: Cancer
Share this entry
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
https://health-outcomes-observatory.eu/wp-content/uploads/2021/12/Help-us-develop-H2O-so-it-leads-to-improved-dialogue-between-patients-and-doctors-to-drive-better-care-9.jpg 900 1600 h2o https://health-outcomes-observatory.eu/wp-content/uploads/2021/01/H2O-logo-hor-300x98.png h2o2021-12-17 14:46:462021-12-21 08:35:02Study shows integration with health care systems remains critical to success

NEWSLETTER

Sign up to stay informed

Recent Posts

  • Creation of the independent legal entity of the H20 (Health Outcomes Observatory) project in Spain.
  • H2O response to the new European Health Data Space (EHDS)
  • Unleashing the Power of PROS – an H2O Hosted Conversation
  • Please join us for our Open House Sessions in May 2022

ACKNOWLEDGEMENT

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 945345-2. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Trial Nation and JDRF.

About IMI

The Innovative Medicines Initiative is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). It is working to improve health by speeding up the development of the next generation of medicines, particularly in areas where there is an unmet medical or social need. It works by facilitating collaboration between the key players involved in health research, including universities, research centres, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is the world’s biggest public-private partnership (PPP) in the life sciences. http://www.imi.europa.eu/

Legal notice
Privacy Policy
Cookies Policy

       




H2O welcomes Power UP report H2O, collaborating with public health partners to lead and advise the first...
Scroll to top
Non exempt cookies, proprietary cookies and third-party cookies are used to identify the browsing preferences and habits of users and to offer a better experience. Please consult our cookie policy here.
Cookie SettingsAccept all Reject All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT